 <h1>Paromycin Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>paromomycin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about paromomycin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Paromycin.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to paromomycin: oral capsule</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, paromomycin (the active ingredient contained in Paromycin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of paromomycin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>diarrhea</li>
<li>nausea</li>
</ul><p>
<!-- end oral capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to paromomycin: oral capsule</i></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Nausea, abdominal cramps, diarrhea, gastrointestinal intolerance, vomiting, abdominal discomfort, pancreatitis, elevated serum amylase<sup>[Ref]</sup></p><p>Nausea, abdominal cramps, and diarrhea have been reported with doses greater than 3 g/day.</p>
<p></p>
<p>A patient with AIDS developed pancreatitis after 5 days of therapy with this drug for cryptosporidiosis.  Serum amylase declined progressively after this drug was discontinued but became elevated after reinstitution of therapy.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Ototoxicity and sensorineural damage have been reported, usually in patients who also had hepatic disease.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Ototoxicity, sensorineural damage, headache, vertigo<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Transient elevated AST (greater than 3 times the upper limit of normal [3 x ULN]) and ALT (greater than 3 x ULN) were reported in patients receiving an IM formulation during a clinical study.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Elevated AST, elevated ALT<sup>[Ref]</sup></p><h3>Other</h3><p>Pyrexia was reported in patients receiving an IM formulation during a clinical study.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Pyrexia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Injection site pain, injection site swelling<sup>[Ref]</sup></p><p>Injection site pain and swelling were reported in patients receiving an IM formulation during a clinical study.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online] Available from: URL: http://online.tg.org.au/complete/desktop/tgc.htm."   ([2014, Nov -]):</p><p id="ref_2">2. Tan WW, Chapnick EK, Abter EIM, Haddad S, Zimbalist EH, Lutwick LI "Paromomycin-associated pancreatitis HIV-related cryptosporidiosis." Ann Pharmacother 29 (1995): 22-4</p><p id="ref_3">3. "Product Information. Humatin (paromomycin)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_4">4. Sundar S,  Jha TK,  Thakur CP,  Sinha PK,  Bhattacharya SK "Injectable paromomycin for Visceral leishmaniasis in India." N Engl J Med 356 (2007): 2571-81</p><p id="ref_5">5. Sullam PM, Slutkin G, Gottlieb AB, Mills J "Paromomycin therapy of endemic amebiasis in homosexual men." Sex Transm Dis 13 (1986): 151-5</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Paromycin (paromomycin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: amebicides</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Humatin</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Amebiasis</li>
<li>Beef Tapeworm Infection (Taenia saginata)</li>
<li>Cryptosporidiosis</li>
<li>Dientamoeba fragilis</li>
<li data-more-config-id="list-data-resources-conditions">... +6 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to paromomycin: oral capsule</i></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Nausea, abdominal cramps, diarrhea, gastrointestinal intolerance, vomiting, abdominal discomfort, pancreatitis, elevated serum amylase<sup>[Ref]</sup></p><p>Nausea, abdominal cramps, and diarrhea have been reported with doses greater than 3 g/day.</p><p></p><p>A patient with AIDS developed pancreatitis after 5 days of therapy with this drug for cryptosporidiosis.  Serum amylase declined progressively after this drug was discontinued but became elevated after reinstitution of therapy.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Ototoxicity and sensorineural damage have been reported, usually in patients who also had hepatic disease.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Ototoxicity, sensorineural damage, headache, vertigo<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Transient elevated AST (greater than 3 times the upper limit of normal [3 x ULN]) and ALT (greater than 3 x ULN) were reported in patients receiving an IM formulation during a clinical study.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Elevated AST, elevated ALT<sup>[Ref]</sup></p><h3>Other</h3><p>Pyrexia was reported in patients receiving an IM formulation during a clinical study.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Pyrexia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Injection site pain, injection site swelling<sup>[Ref]</sup></p><p>Injection site pain and swelling were reported in patients receiving an IM formulation during a clinical study.<sup>[Ref]</sup></p><p id="ref_1">1. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online] Available from: URL: http://online.tg.org.au/complete/desktop/tgc.htm."   ([2014, Nov -]):</p><p id="ref_2">2. Tan WW, Chapnick EK, Abter EIM, Haddad S, Zimbalist EH, Lutwick LI "Paromomycin-associated pancreatitis HIV-related cryptosporidiosis." Ann Pharmacother 29 (1995): 22-4</p><p id="ref_3">3. "Product Information. Humatin (paromomycin)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_4">4. Sundar S,  Jha TK,  Thakur CP,  Sinha PK,  Bhattacharya SK "Injectable paromomycin for Visceral leishmaniasis in India." N Engl J Med 356 (2007): 2571-81</p><p id="ref_5">5. Sullam PM, Slutkin G, Gottlieb AB, Mills J "Paromomycin therapy of endemic amebiasis in homosexual men." Sex Transm Dis 13 (1986): 151-5</p><h2>More about Paromycin (paromomycin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: amebicides</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Amebiasis</li>
<li>Beef Tapeworm Infection (Taenia saginata)</li>
<li>Cryptosporidiosis</li>
<li>Dientamoeba fragilis</li>
<li data-more-config-id="list-data-resources-conditions">... +6 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>